KalVista Pharmaceuticals, Inc. (KALV) Insider Ownership

Historic Insider Ownership Trends

KalVista Pharmaceuticals's top three insider shareholders as of July 24, 2026 are Healthcare Capital Partners Iii, L.P. Venrock (TenPercentOwner, 5.09Mn shares), Benjamin L Palleiko (Chief Executive Officer, 462.58K shares), Christopher Yea (Chief Development Officer, 226.70K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Benjamin L Palleiko Chief Executive Officer 462,577 0 20 Apr, 2026
Thomas Andrew Crockett Ceo 211,203 0 21 Feb, 2024
Edward P. Feener Chief Scientific Officer 72,858 0 21 May, 2024
Christopher Yea Chief Development Officer 226,701 0 24 Feb, 2026
Healthcare Capital Partners Iii, L.P. Venrock - 0 5,089,354 27 Mar, 2026
Brian Piekos Chief Financial Officer 18,150 0 20 Apr, 2026
Nicole Sweeny Chief Commercial Officer 51,391 0 20 Apr, 2026
Paul K. Audhya Chief Medical Officer 142,547 0 20 Apr, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
16 Apr, 2026 Brian Piekos Common Stock A 6,250 - 20,012 D M
16 Apr, 2026 Nicole Sweeny Common Stock A 6,250 - 53,253 D M
16 Apr, 2026 Nicole Sweeny Common Stock A 6,250 - 53,253 D M
16 Apr, 2026 Brian Piekos Common Stock A 6,250 - 20,012 D M
16 Apr, 2026 Paul K. Audhya Common Stock A 6,250 - 145,233 D M
16 Apr, 2026 Benjamin L Palleiko Common Stock A 20,312 - 472,127 D M
16 Apr, 2026 Brian Piekos Common Stock A 6,250 - 20,012 D M
16 Apr, 2026 Nicole Sweeny Common Stock A 6,250 - 53,253 D M
17 Apr, 2026 Nicole Sweeny Common Stock D 1,862 $20.22 51,391 D S
17 Apr, 2026 Nicole Sweeny Common Stock D 1,862 $20.22 51,391 D S
17 Apr, 2026 Brian Piekos Common Stock D 1,862 $20.22 18,150 D S
17 Apr, 2026 Brian Piekos Common Stock D 1,862 $20.22 18,150 D S
17 Apr, 2026 Nicole Sweeny Common Stock D 1,862 $20.22 51,391 D S
17 Apr, 2026 Brian Piekos Common Stock D 1,862 $20.22 18,150 D S
17 Apr, 2026 Benjamin L Palleiko Common Stock D 9,550 $20.22 462,577 D S
17 Apr, 2026 Paul K. Audhya Common Stock D 2,686 $20.22 142,547 D S
16 Apr, 2026 Brian Piekos Restricted Stock Unit D 6,250 $0.00 93,750 D M
16 Apr, 2026 Brian Piekos Restricted Stock Unit D 6,250 $0.00 93,750 D M
16 Apr, 2026 Nicole Sweeny Restricted Stock Unit D 6,250 $0.00 93,750 D M
16 Apr, 2026 Nicole Sweeny Restricted Stock Unit D 6,250 $0.00 93,750 D M